Limiting toxicities during intensified remission induction chemotherapy for childhood acute lymphocytic leukemia.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D012074:Remission Induction; D012306:Risk; D012640:Seizures / Q000139:chemically induced*